Delcath Systems, an interventional oncology company focused on the treatment of rare primary and metastatic cancers of the liver, has entered into a debt facility with Avenue Venture Opportunities Fund, providing up to $20 million with an initial $15 million funded at close. Read more.
Related Posts
Catholic Health, Lenders Reach Forbearance Agreement Over $44M Loan
Catholic Health entered a forbearance agreement earlier this month after it failed to get a long-term debt service coverage ratio of at least 1.0 in the last two years, the report said. This led to an "event of default" on bonds.
May 23, 2023
Guaranteed Raises $6.5M Seed Round to Modernize End-of-Life Care
BrandProject led, with participation from Precursor Ventures, Springbank Ventures, Lakehouse Ventures, and Cake Ventures.
November 4, 2022
St. Louis Senior Housing Project Scores $36M Construction Loan
Shelbourne at Chesterfield will be a 150-unit senior housing project in Chesterfield, Mo.
September 9, 2021
Texas Children’s Hospital Opens Panda Cares® Centers Of Hope with $5.9M Gift
The goal is to provide Heart Center patients with a physical and virtual space as a resource for individualized exercise programs, nutritional guidance, and physical and occupational therapies.
November 7, 2022